These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26583330)

  • 1. SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2.
    Sun R; Jiang B; Qi H; Zhang X; Yang J; Duan J; Li Y; Li G
    Cell Death Dis; 2015 Nov; 6(11):e1990. PubMed ID: 26583330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines.
    Tang Y; Hou J; Li G; Song Z; Li X; Yang C; Liu W; Hu Y; Xu Y
    Oncol Rep; 2014 Nov; 32(5):2168-74. PubMed ID: 25200103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of NEAT1/miR-133a axis in promoting cervical cancer progression via targeting SOX4.
    Yuan LY; Zhou M; Lv H; Qin X; Zhou J; Mao X; Li X; Xu Y; Liu Y; Xing H
    J Cell Physiol; 2019 Aug; 234(10):18985-18993. PubMed ID: 30932200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
    Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
    Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202.
    Cheng C; Liu ZG; Zhang H; Xie JD; Chen XG; Zhao XQ; Wang F; Liang YJ; Chen LK; Singh S; Chen JJ; Talele TT; Chen ZS; Zhong FT; Fu LW
    Mol Pharm; 2012 Jul; 9(7):1971-82. PubMed ID: 22632055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.
    Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY
    Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of ABCG2 inhibits cancer cell proliferation.
    Chen Z; Liu F; Ren Q; Zhao Q; Ren H; Lu S; Zhang L; Han Z
    Int J Cancer; 2010 Feb; 126(4):841-51. PubMed ID: 19642144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulated SOX4 expression suppresses cell proliferation, metastasis and induces apoptosis in Xuanwei female lung cancer patients.
    Zhou Y; Wang X; Huang Y; Chen Y; Zhao G; Yao Q; Jin C; Huang Y; Liu X; Li G
    J Cell Biochem; 2015 Jun; 116(6):1007-18. PubMed ID: 25565486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
    Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
    Ding XW; Wu JH; Jiang CP
    Life Sci; 2010 Apr; 86(17-18):631-7. PubMed ID: 20159023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
    Li R; Liu GZ; Luo SY; Chen R; Zhang JX
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2.
    Hamada S; Satoh K; Hirota M; Kanno A; Umino J; Ito H; Masamune A; Kikuta K; Kume K; Shimosegawa T
    J Cell Physiol; 2012 Feb; 227(2):729-38. PubMed ID: 21465479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLAC8 contributes to the malignant behaviors of cervical cancer cells by activating the SOX4-mediated AKT pathway.
    Deng B; Zhang S; Zhou Y; Zhu Y; Fei J; Li A
    Histochem Cell Biol; 2023 May; 159(5):439-451. PubMed ID: 36602585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells.
    Mosaffa F; Kalalinia F; Lage H; Afshari JT; Behravan J
    Mol Cell Biochem; 2012 Apr; 363(1-2):385-93. PubMed ID: 22193459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells.
    To KK; Yu L; Liu S; Fu J; Cho CH
    Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells.
    Ke SZ; Ni XY; Zhang YH; Wang YN; Wu B; Gao FG
    Int J Oncol; 2013 Apr; 42(4):1289-96. PubMed ID: 23381786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.